Related Experiment Video
Updated: Jun 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Secondary organizing pneumonia after pneumococcal pneumonia]
Shusaku Haranaga1, Maki Tamayose, Hideta Nakamura
1Department of Medicine and Therapeutics, Control and Prevention of Infectious Disease, Faculty of Medicine, University of the Ryukus, Okinawa.
This case study highlights organizing pneumonia as a complication of acute pneumococcal pneumonia. Early steroid treatment rapidly resolved lung volume loss, suggesting a new therapeutic approach.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pathology
Background:
- Pneumococcal pneumonia is a common bacterial infection, typically treated with antibiotics.
- Severe cases can lead to complications, but organizing pneumonia is an unusual sequela.
Observation:
- A 28-year-old woman presented with symptoms of pneumococcal pneumonia.
- Initial antibiotic treatment improved acute symptoms and radiographic infiltration.
- However, severe right lung volume loss developed, indicating a potential complication.
Findings:
- Bronchoalveolar lavage fluid showed lymphocytosis.
- Transbronchial lung biopsy revealed Masson bodies, consistent with organizing pneumonia.
- Prompt administration of prednisolone led to rapid resolution of lung volume loss.
Implications:
- This case suggests that organizing pneumonia can occur during acute pneumococcal pneumonia.
- Early corticosteroid therapy may be effective in managing this complication.
- Further research is warranted to understand the pathophysiology and optimal treatment strategies.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: